SUBSCRIBE
SUBSCRIBE
News   Policy

Johnson & Johnson Plant in Merck & Co., Inc. Venture Cited by U.S. FDA

July 20, 2010 | 
1 min read
Reuters -- Johnson & Johnson (JNJ.N) has been cited by U.S. regulators for problems at a plant that is part of a consumer medicines joint venture with Merck & Co Inc (MRK.N), in a fresh blow to its manufacturing operations.
Regulatory
Johnson & Johnson Family of Companies Merck & Co.
MORE ON THIS TOPIC
Podcast
Vertex carries M&A uptick into H2, IPOs and VC raises also grow, FDA on pace despite turmoil
July 8, 2026
 · 
1 min read
 · 
Jef Akst
Digital scanning effect of human kidneys glowing in blue, highlighting intricate details with a futuristic design. The image emphasizes respiratory system anatomy and health.
Approvals
Vera moves into growing kidney disease space with FDA’s accelerated IgAN nod
July 7, 2026
 · 
2 min read
 · 
Annalee Armstrong
Creative photo collage geometry figures scales platform weight hands body fragments pointing finger stability spheres measure.
FDA
Despite chaos and churn, FDA decisions hold mostly steady in H1 2026
July 6, 2026
 · 
8 min read
 · 
Tristan Manalac
Editorial
Biotech’s China problem: An issue of national security or economic value for the US?
July 2, 2026
 · 
6 min read
 · 
Jef Akst